MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-20-0004270
Vasista Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹162.88 Cr
▲ 19% YoY
Net profit · FY 2025
₹1.05 Cr
Net margin 0.6%
EBITDA · FY 2025
₹12.4 Cr
EBITDA margin 7.6%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹11.51 Cr
Satisfied ₹18.84 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
42
Provident fund records
About Vasista Life Sciences Private Limited
Data last updated:
Vasista Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC067618. Its GSTIN is 36AADCV2601C1ZW (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors including Potturi Narayana Raju (Managing Director) and Ganapathi Raju Venkataappala Narasimha Varma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D No 11 – 6 – 53/2/5 Opp:Idpl Main Gate Beside Line To M R Steels Balanagar, Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2025, the company reported a revenue of ₹162.88 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Cr (net margin 0.6%) and EBITDA of ₹12.4 Cr (EBITDA margin 7.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 23% over five years.
The company has about 42 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Vasista Life Sciences. As per MCA filings, the company has open charges of ₹11.51 Cr and satisfied charges of ₹18.84 Cr on record. The company has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in November 2020. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Srini Pharmaceuticals Private Limited with revenue of ₹165.56 Cr. The company has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 43 overdue payments to 24 micro and small suppliers.
Vasista Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0004270). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vasista.co.in.
Company details
CIN U24232TG2010PTC067618
Registration Number 067618
Incorporation Date 19 March 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0004270
CIN history
Vasista Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2010PTC067618. The current CIN is U24232TG2010PTC067618, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2010PTC067618 | Current |
| U24232AP2010PTC067618 | Previous |
Key People
Potturi Narayana Raju Managing Director Ganapathi Raju Venkataappala Narasimha Varma Director Satya Bangara Srirama Chandra Varma Kanumuri Director Recognitions & Rankings of Vasista Life Sciences
Contact details
Vasista Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is vasista.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressD No 11 – 6 – 53/2/5 Opp:Idpl Main Gate Beside Line To M R Steels Balanagar, Hyderabad, Telangana, India – 500037
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vasista Life Sciences Private Limited, buy the company report.
Comprehensive company report
Vasista Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vasista Life Sciences operates one associated brand: Vasista Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies active pharmaceutical ingredients, intermediates, and specialty chemicals. | vasistalife.com |
Business activity
The main business activity of Vasista Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vasista Life Sciences Private Limited, buy the company report.
Financials of Vasista Life Sciences Private Limited
FY 2025 filings availableVasista Life Sciences Private Limited reported revenue of ₹162.88 Cr (up 19% YoY) for FY 2025.
Revenue · FY 2025
₹162.88 Cr ▲ 19%
Net profit · FY 2025
₹1.05 Cr margin 0.6%
EBITDA · FY 2025
₹12.4 Cr margin 7.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 10%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 1%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 19% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.6% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vasista Life Sciences Private Limited, buy the company report.
Board of directors of Vasista Life Sciences Private Limited
Vasista Life Sciences has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganapathi Raju Venkataappala Narasimha Varma | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
| Satya Bangara Srirama Chandra Varma Kanumuri | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
| Potturi Akhil Varma | Additional Director | 28 Nov 2022 | 3 Years 10 Months | Current |
| Raja Rajeswari Potturi | Director | 16 Aug 2018 | 8 Years 2 Months | Current |
| Potturi Narayana Raju | Managing Director | 19 Mar 2010 | 16 Years 7 Months | Current |
| Yerramsetty Srinivasan | Director | 24 Aug 2021 | 5 Years 1 Months | Current |
Peer comparison
Vasista Life Sciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Srini Pharmaceuticals Private Limited | ₹165.56 Cr (FY 2024) | -18.0% | Hyderabad, Telangana, India | |||
| Chromo Laboratories India Private Limited | ₹164.91 Cr (FY 2025) | -6.0% | Patancheru, Telangana, India | |||
| Calyx Chemicals and Pharmaceuticals Limited | ₹163.62 Cr (FY 2024) | -21.0% | Thane, Maharashtra, India | |||
| S.V. Labs Private Limited | ₹162.99 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Vasista Life Sciences Private Limitedthis company | ₹162.88 Cr (FY 2025) | ₹1.05 Cr | 0.6% | 19.0% | 42 | Hyderabad, Telangana, India |
| Syntho Chirals Private Limited | ₹162.38 Cr (FY 2024) | 23.0% | Hyderabad, Telangana, India | |||
| Vivin Drugs & Pharmaceuticals Private Limited | ₹161.52 Cr (FY 2023) | -25.0% | Hyderabad, Telangana, India | |||
| Valentis Laboratories Private Limited | ₹160.96 Cr (FY 2025) | 135.0% | Sangareddy, Telangana, India | |||
| Everest Organics Limited | ₹160.17 Cr (FY 2025) | -19.0% | Medak, Telangana, India |
To see the full peer comparison of Vasista Life Sciences Private Limited, buy the company report.
Auditor
Vasista Life Sciences Private Limited is audited by NAGARAJARAOB for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAGARAJARAOB | FY 2023 | 022704 |
Shareholding
The shareholding of Vasista Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Vasista Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹11.51 Cr
Satisfied charges
₹18.84 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2023 | 100848268 | Axis Bank Limited | ₹20 Lakh | Open | |
| 29 Mar 2022 | 100566365 | Others | ₹81 Lakh | Open | |
| 16 Oct 2018 | 100213783 | Others | ₹10.5 Cr | Open | |
| 22 Dec 2020 | 100443515 | Hdfc Bank Limited | ₹11.57 Cr | Satisfied | |
| 16 Oct 2020 | 100388217 | Others | ₹1.57 Cr | Satisfied |
To see the full charge records of Vasista Life Sciences Private Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Vasista Life Sciences Private Limited has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in November 2020.
Total deals
5
Secondary share transfers
3
Funding rounds
2
Disclosed funding
₹1.49 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2018 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2015 | Funding round | ₹50 Lakh | Investors: 4 individuals |
| Mar 2013 | Funding round | ₹99 Lakh | Investors: 4 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vasista Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Vasista Life Sciences Private Limited was last rated by Crisil on 29 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 29 Oct 2021 |
To see the full credit ratings and regulatory alerts of Vasista Life Sciences Private Limited, buy the company report.
MSME payment delays
Vasista Life Sciences Private Limited has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 43 overdue payments to 24 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 24)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vestro Solvents Private Limited | |||
| Sreeja Chemicals | |||
| Sri Sai Durga Scientifics | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Vasista Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Vasista Life Sciences has 1 subsidiary company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Vasista Pharma Chem Private Limited | U24297AP2015PTC096994 |
To see the full group structure of Vasista Life Sciences Private Limited, buy the company report.
Employees & EPFO
Vasista Life Sciences Private Limited has a workforce of 42 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
42
Active EPFO establishments
1
Employee growth
5%
GST
Vasista Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCV2601C1ZW | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vasista Life Sciences Private Limited, buy the company report.
Recent activity
Vasista Life Sciences Private Limited has 12 board changes on record since 2010: 6 appointments and 6 cessations. The latest: Potturi Akhil Varma was appointed as Additional Director on 28 Nov 2022.
AGM
Vasista Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 16 Oct 2020 via Charge ID 100388217 with Others was fully satisfied on 19 Jun 2025.
Filing
Vasista Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100848268 was registered on 31 Dec 2023.
Appointed
Potturi Akhil Varma was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 0.81 Cr with Charge ID 100566365 was registered on 29 Mar 2022.
Charges
A charge registered on 22 Dec 2020 via Charge ID 100443515 with Hdfc Bank Limited was fully satisfied on 15 Mar 2022.
Appointed
Yerramsetty Srinivasan was appointed as Director.
Ceased
Potturi Akhil Varma ceased to be Director.
Charges
A charge with Others of Rs. 10.50 Cr registered on 16 Oct 2018 with Charge ID 100213783 was modified on 19 Feb 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 11.57 Cr with Charge ID 100443515 was registered on 22 Dec 2020.
Charges
A charge with Others amounted to Rs. 1.57 Cr with Charge ID 100388217 was registered on 16 Oct 2020.
13 earlier events are in the company report.
Frequently asked questions
Vasista Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 March 2010 (16+ years old) and is registered under CIN U24232TG2010PTC067618.
Vasista Life Sciences has 6 current directors:
- Potturi Narayana Raju - Managing Director
- Ganapathi Raju Venkataappala Narasimha Varma - Director
- Satya Bangara Srirama Chandra Varma Kanumuri - Director
- Potturi Akhil Varma - Additional Director
- Raja Rajeswari Potturi - Director
- Yerramsetty Srinivasan - Director
The latest financial statements of Vasista Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vasista Life Sciences is 36AADCV2601C1ZW, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Vasista Life Sciences is U24232TG2010PTC067618. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vasista Life Sciences was incorporated on 19 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vasista Life Sciences has 5 deals on record (3 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.49 Cr; the latest was in November 2020.
The peers of Vasista Life Sciences by revenue are Srini Pharmaceuticals Private Limited, Chromo Laboratories India Private Limited, Calyx Chemicals and Pharmaceuticals Limited, S.V. Labs Private Limited, Syntho Chirals Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Potturi Akhil Varma was appointed as Additional Director on 28 Nov 2022. Yerramsetty Srinivasan was appointed as Director on 24 Aug 2021. Potturi Akhil Varma ceased to be Director on 20 Jul 2021. Vasista Life Sciences has 12 board changes on record in total.
Yes, Vasista Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0004270).
Vasista Life Sciences has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 43 overdue payments to 24 micro and small suppliers. The latest return was filed on 30 Oct 2019.
Vasista Life Sciences can be reached through the website vasista.co.in. Its registered office is in Hyderabad, Telangana, India.